#SaxoStrats. UPDATE: Valeant position closed with a gain
We initiated a long position in Valeant Pharmaceuticals International, Inc (VRX:xnys) on November 11, 2015.
Management and risk description
We have closed our position in Quebec-based Valeant for a gain of 8.3%. We are concerned about the fallout from the US Congressional hearings over drug pricing and hence choose to take profit now.
— Edited by John Acher
Non-independent investment research disclaimer applies. Read more